annual CFO:
-$122.20M-$71.98M(-143.33%)Summary
- As of today (May 29, 2025), VRNA annual cash flow from operations is -$122.20 million, with the most recent change of -$71.98 million (-143.33%) on December 31, 2024.
- During the last 3 years, VRNA annual CFO has fallen by -$88.95 million (-267.48%).
- VRNA annual CFO is now -3594305.88% below its all-time high of $3400.00, reached on December 31, 2005.
Performance
VRNA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$11.56M+$17.27M(+59.91%)Summary
- As of today (May 29, 2025), VRNA quarterly cash flow from operations is -$11.56 million, with the most recent change of +$17.27 million (+59.91%) on March 31, 2025.
- Over the past year, VRNA quarterly CFO has increased by +$2.05 million (+15.06%).
- VRNA quarterly CFO is now -150.65% below its all-time high of $22.82 million, reached on September 30, 2021.
Performance
VRNA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$120.15M+$2.05M(+1.68%)Summary
- As of today (May 29, 2025), VRNA TTM cash flow from operations is -$120.15 million, with the most recent change of +$2.05 million (+1.68%) on March 31, 2025.
- Over the past year, VRNA TTM CFO has dropped by -$62.10 million (-106.98%).
- VRNA TTM CFO is now -2625.75% below its all-time high of -$4.41 million, reached on March 31, 2017.
Performance
VRNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRNA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -143.3% | +15.1% | -107.0% |
| 3 y3 years | -267.5% | +20.3% | -311.3% |
| 5 y5 years | -185.1% | +12.6% | -178.0% |
VRNA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -267.5% | at low | -100.0% | +81.5% | -321.2% | +1.7% |
| 5 y | 5-year | -267.5% | at low | -150.7% | +81.5% | -321.2% | +1.7% |
| alltime | all time | <-9999.0% | at low | -150.7% | +81.5% | -2625.8% | +1.7% |
VRNA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$11.56M(-59.9%) | -$120.15M(-1.7%) |
| Dec 2024 | -$122.20M(+143.3%) | -$28.84M(-54.0%) | -$122.20M(+17.8%) |
| Sep 2024 | - | -$62.66M(+266.4%) | -$103.77M(+92.7%) |
| Jun 2024 | - | -$17.10M(+25.7%) | -$53.84M(-7.3%) |
| Mar 2024 | - | -$13.61M(+30.8%) | -$58.05M(+15.6%) |
| Dec 2023 | -$50.22M(-16.1%) | -$10.40M(-18.3%) | -$50.22M(+5.6%) |
| Sep 2023 | - | -$12.73M(-40.3%) | -$47.56M(-10.1%) |
| Jun 2023 | - | -$21.31M(+268.6%) | -$52.93M(+3.5%) |
| Mar 2023 | - | -$5.78M(-25.3%) | -$51.13M(-14.6%) |
| Dec 2022 | -$59.86M(+80.0%) | -$7.74M(-57.2%) | -$59.86M(-13.8%) |
| Sep 2022 | - | -$18.09M(-7.3%) | -$69.45M(+143.4%) |
| Jun 2022 | - | -$19.52M(+34.5%) | -$28.53M(-2.4%) |
| Mar 2022 | - | -$14.51M(-16.2%) | -$29.21M(-12.1%) |
| Dec 2021 | -$33.25M(-26.2%) | -$17.32M(-175.9%) | -$33.25M(-4.2%) |
| Sep 2021 | - | $22.82M(-213.0%) | -$34.73M(-48.6%) |
| Jun 2021 | - | -$20.20M(+8.9%) | -$67.55M(+34.0%) |
| Mar 2021 | - | -$18.55M(-1.3%) | -$50.40M(+11.8%) |
| Dec 2020 | -$45.08M(+5.2%) | -$18.80M(+88.0%) | -$45.08M(+19.1%) |
| Sep 2020 | - | -$10.00M(+226.6%) | -$37.83M(+4.4%) |
| Jun 2020 | - | -$3.06M(-76.9%) | -$36.24M(-16.2%) |
| Mar 2020 | - | -$13.22M(+14.5%) | -$43.23M(+0.8%) |
| Dec 2019 | -$42.87M | -$11.55M(+37.5%) | -$42.87M(+15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$8.40M(-16.4%) | -$37.29M(+25.3%) |
| Jun 2019 | - | -$10.05M(-21.9%) | -$29.75M(+9.8%) |
| Mar 2019 | - | -$12.86M(+115.5%) | -$27.11M(+17.9%) |
| Dec 2018 | -$22.98M(-17.8%) | -$5.97M(+585.6%) | -$22.98M(-3.6%) |
| Sep 2018 | - | -$870.80K(-88.2%) | -$23.83M(-28.9%) |
| Jun 2018 | - | -$7.40M(-15.3%) | -$33.50M(+3.7%) |
| Mar 2018 | - | -$8.74M(+28.1%) | -$32.30M(+15.5%) |
| Dec 2017 | -$27.97M(+305.8%) | -$6.82M(-35.3%) | -$27.97M(+32.3%) |
| Sep 2017 | - | -$10.54M(+69.9%) | -$21.15M(+99.3%) |
| Jun 2017 | - | -$6.20M(+40.7%) | -$10.61M(+140.7%) |
| Mar 2017 | - | -$4.41M | -$4.41M |
| Dec 2016 | -$6.89M(-26.8%) | - | - |
| Dec 2015 | -$9.42M(+70.9%) | - | - |
| Dec 2014 | -$5.51M(+62.7%) | - | - |
| Dec 2013 | -$3.39M(-17.0%) | - | - |
| Dec 2012 | -$4.08M(+67.0%) | - | - |
| Dec 2011 | -$2.44M(-4.6%) | - | - |
| Dec 2010 | -$2.56M(-2.3%) | - | - |
| Dec 2009 | -$2.62M(+32.6%) | - | - |
| Dec 2008 | -$1.98M(-17.3%) | - | - |
| Dec 2007 | -$2.39M(+247.5%) | - | - |
| Dec 2006 | -$687.70K(<-9900.0%) | - | - |
| Dec 2005 | $3400.00 | - | - |
FAQ
- What is Verona Pharma annual cash flow from operations?
- What is the all time high annual CFO for Verona Pharma?
- What is Verona Pharma annual CFO year-on-year change?
- What is Verona Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Verona Pharma?
- What is Verona Pharma quarterly CFO year-on-year change?
- What is Verona Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Verona Pharma?
- What is Verona Pharma TTM CFO year-on-year change?
What is Verona Pharma annual cash flow from operations?
The current annual CFO of VRNA is -$122.20M
What is the all time high annual CFO for Verona Pharma?
Verona Pharma all-time high annual cash flow from operations is $3400.00
What is Verona Pharma annual CFO year-on-year change?
Over the past year, VRNA annual cash flow from operations has changed by -$71.98M (-143.33%)
What is Verona Pharma quarterly cash flow from operations?
The current quarterly CFO of VRNA is -$11.56M
What is the all time high quarterly CFO for Verona Pharma?
Verona Pharma all-time high quarterly cash flow from operations is $22.82M
What is Verona Pharma quarterly CFO year-on-year change?
Over the past year, VRNA quarterly cash flow from operations has changed by +$2.05M (+15.06%)
What is Verona Pharma TTM cash flow from operations?
The current TTM CFO of VRNA is -$120.15M
What is the all time high TTM CFO for Verona Pharma?
Verona Pharma all-time high TTM cash flow from operations is -$4.41M
What is Verona Pharma TTM CFO year-on-year change?
Over the past year, VRNA TTM cash flow from operations has changed by -$62.10M (-106.98%)